Drug Development

Thomas Paust is global director of marketing at Sartorius Stedim Biotech GmbH in Goettingen, Germany.

Articles

The authors describe the origins of single-use components and explain their application to aseptic processes. They also show how disposable devices have changed over time and offer a glimpse of the future.

The Evolution of Single-Use Technologies in Aseptic Processing

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Growth in the market for monoclonal antibodies, recombinant proteins, and vaccines creates new opportunities for drug companies and suppliers.

Moving to the Next Level in Biomanufacturing

Emerging markets remain an important element in the strategies of pharmaceutical companies and their suppliers.

Navigating the Global Pharmaceutical Supply Chain

Arthur J. Falk, PhD, is president and CDO of International Pharmaceutical Excipient Auditing (IPEA).

It's time to maintain a thorough traceable excipient trail.

Inside IPEC: Excipient Pedigree as a Supply Chain Tool

Michelle Hoffman, editorial director of Pharmaceutical Technology.

The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.

Trends in Bioprocessing

Pharmaceutical Technology talked to drugmakers, equipment vendors, and service providers to learn more about the advantages and disadvantages of rapid microbial-detection methods.

An Overview of Rapid Microbial-Detection Methods

As contract manufacturers and drug companies meet at Informex, the stage is set for the latest in pharmaceutical chemical development.

Advances in Custom Synthesis

Angie Drakulich was editorial director of Pharmaceutical Technology.

Leading experts share insight on the current and future direction of process analytical technology. This article contains bonus online material.

PAT: A New Dawn for Drug Product Quality

The authors sought to improve the productivity of protein synthesis by using a highly active cell-free extract from Escherichia coli and by optimizing buffer conditions and shaking conditions.

Large-Scale Protein Production with a Cell-Free System

Leading experts share insight on polymorphism and crystallization.

APIs and Excipients